Non-clinical safety assessment of acoziborole (SCYX-7158) to support human african trypanosomiasis (HAT or "sleeping sickness"). POP: 09/01/2019 to 08/31/2020.
Ended Awarded Last action
- Contract number
- 75N95019F00091
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,156,165
Award facts
- Opportunity
-
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Pre-Solicitation · N01TR172002 · Posted Apr 7, 2020
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Award Notice · Posted May 2, 2016
- Contract value 100% obligated
- $1,156,165.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chicago, IL 60616, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$35,321 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $6,647 | |
| Supplemental Agreement for work within scope | $81,140 | |
| Original award | $1,103,699 |
About this award
This is a cost-plus-fixed-fee delivery order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to IIT Research Institute, a non-profit research and technology development organization, to conduct non-clinical safety assessments of acoziborole (SCYX-7158) to support human African trypanosomiasis (HAT) drug development. The $1,156,165.39 delivery order is under the "CRO Support for NCATS In Vitro and In Vivo Toxicology Studies" indefinite delivery/indefinite quantity contract, which enables the NIH to leverage IIT Research Institute's preclinical drug testing capabilities on an as-needed basis. No set-aside designation was used. As the parent organization, the Illinois Institute of Technology has a history of providing research, prototypes, technologies, and educational services to federal agencies through contracts and grants.
Quick answers
Who was awarded contract 75N95019F00091?
75N95019F00091 was awarded to IIT Research Institute by National Institute on Drug Abuse (National Institutes of Health) on September 1, 2019.
How much is contract 75N95019F00091 worth?
The government has obligated $1,156,165 on 75N95019F00091.
Which agency awarded contract 75N95019F00091?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019F00091, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95019F00091 an order under another contract?
Yes. 75N95019F00091 is a delivery order under HHSN271201700016I, an indefinite delivery contract, on CRO Support for NCATS In Vitro and In Vivo Toxicology Studies.
Was contract 75N95019F00091 competed?
The extent of competition for 75N95019F00091 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award